mer-/-mer
Mercury-containing drugs, once used as antiseptics or diuretics.
- Drugs containing mer-/-mer: 37
- Approved somewhere: 13
- With a US drug page: 9
- Stem
- mer-/-mer
- Class
- Mercury-containing drugs, once used as antiseptics or diuretics
Approved and clinical-stage drugs in ChEMBL whose names containing mer-/-mer, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Berdazimer sodium | Approved | — | Releases NO, antimicrobial |
| Crofelemer | Approved | CFTR, ANO1 | Cystic fibrosis transmembrane conductance regulator inhibitor |
| Glatiramer acetate | Approved | — | Unknown |
| Meropenem | Approved | Bacterial penicillin-binding protein | Bacterial penicillin-binding protein inhibitor |
| Patiromer sorbitex calcium | Approved | Potassium | Potassium chelating agent |
| Porfimer sodium | Approved | DNA | DNA inhibitor |
| Sevelamer | Approved | — | Unknown |
| Sevelamer hydrochloride | Approved | Phosphate | Phosphate sequestering agent |
| Succimer | Phase 2 | Lead | Lead chelating agent |
| Cadexomer iodine | Approved | — | Unknown |
| Dextranomer | Approved | — | Unknown |
| Mercaptopurine anhydrous | Approved | PPAT, DNA | Amidophosphoribosyltransferase inhibitor |
| Mersalyl | Approved | — | Unknown |
| Patiromer calcium | Approved | Potassium | Potassium chelating agent |
| Astodrimer | Phase 3 | — | Surfactant |
| Patiromer | Phase 3 | Potassium | Potassium chelating agent |
| Poloxamer | Phase 3 | — | — |
| Tolevamer potassium sodium | Phase 3 | TCDA, TCDB | Toxin A binding agent |
| Vepoloxamer | Phase 3 | — | — |
| Veverimer | Phase 3 | Hydrochloric acid | Hydrochloric acid sequestering agent |
| Azoximer bromide | Phase 2 | — | Immunomodulator |
| Carbomer 910 | Phase 2 | — | — |
| Crilanomer | Phase 2 | — | — |
| Daniluromer | Phase 2 | — | — |
| Merestinib | Phase 2 | MET | Hepatocyte growth factor receptor inhibitor |
| Mericitabine | Phase 2 | NS5B | RNA-directed RNA polymerase inhibitor |
| Merimepodib | Phase 2 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 inhibitor |
| Onterodrimer | Phase 2 | — | — |
| Pegfosimer manganese | Phase 2 | — | — |
| Plovamer acetate | Phase 2 | HLA-DRB1 | HLA class II histocompatibility antigen, DRB1-15 beta chain modulator |
| Astodrimer sodium | Phase 1 | — | — |
| Carbomer homopolymer type b (allyl pentaerythritol crosslinked) | Phase 1 | — | — |
| Flurimedrimer (18F) | Phase 1 | — | — |
| Tedromer | Phase 1 | — | — |
| Bixalomer | — | Phosphate | Phosphate sequestering agent |
| Merethoxylline procaine | — | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Tolevamer sodium | — | TCDA, TCDB | Toxin A binding agent |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO